Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator...
Brain
Perceiv AI Welcomes Simona Skerjanec to Board of Directors
Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE...
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference...
Natus to showcase game-changing innovations at Neurocritical Care Society Conference
MIDDLETON, Wis., Oct. 14, 2024 /PRNewswire/ -- Natus Medical Incorporated's innovation in ICU solutions will be on display Oct. 14-18,...
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology...
RETRANSMISSION: Top Young Innovator Announces Dallas-Based Hisham Ahmad as America’s “Top Young Innovator 2024”
DiscoverSTEM Celebrates Innovation with Award-Winning Solutions from Youth Innovators Across the USA and UAE.This release is being retransmitted to correct...
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an...
Natus seeks FDA 510(k) clearance for its highly anticipated point-of-care EEG solution
MIDDLETON, Wis., Oct. 10, 2024 /PRNewswire/ -- Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to...
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment...
Top Young Innovator Announces Dallas-Based Hisham Ahmad as America’s “Top Young Innovator 2024”
DiscoverSTEM Celebrates Innovation with Award-Winning Solutions from Youth Innovators Across the USA and UAE.Dallas, Texas--(Newsfile Corp. - October 9, 2024)...
Nicole Garrett’s Under Pressure Hyperbarics Partners With L.A. Fashion Weekend to Elevate the Health and Wellness Component
Introducing Cutting-Edge Wellness Experiences to the Heart of LA's Fashion SceneLOS ANGELES, CA / ACCESSWIRE / October 9, 2024 /...
Global Health Exhibition to Unveil the World’s Largest Virtual Hospital in Riyadh
Exclusive exhibit will enable attendees to experience simulated patient scenarios and determine treatment and therapy actionsTechnology behind the virtual hospital...
Lexaria’s GLP-1 Human Pilot Study #3 Begins Dosing
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024...
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
BETHESDA, Md., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel...
Vanqua Bio Announces Positive Interim Results from Phase 1 Clinical Trial of VQ-101, an Orally Administered, Brain-Penetrant, Allosteric Activator of GCase for the Treatment of GBA-Parkinson’s and Related Disorders
VQ-101 is the first small molecule to demonstrate > 75% activation of the lysosomal enzyme glucocerebrosidase (GCase) in humansIn healthy...
HAPPY HEALTH RECEIVES FDA CLEARANCE FOR HAPPY RING, REVOLUTIONARY CLINICAL-GRADE SMART RING AND COMPREHENSIVE DIGITAL HEALTH PLATFORM
AUSTIN, Texas, Oct. 8, 2024 /PRNewswire/ -- Happy Health, an innovative health technology company based in Austin, TX, has received...
New Study Confirms the Accuracy of BrainCheck Assess in Comparison with Widely-Used Montreal Cognitive Assessment (MoCA)
Study published in Frontiers in Psychology shows BrainCheck Assess is a reliable and accurate digital cognitive assessment AUSTIN, Texas, Oct. 8,...